vimarsana.com

Page 15 - ஓஹியோ நிலை பல்கலைக்கழகம் விரிவான புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pelotonia raises less for cancer, but format change is a keeper

In the face of a pandemic and a subsequent change of format, Pelotonia officials announced yesterday that this year s installment of the event raised $10.5 million. That was less than half as much as the previous year, but president and chief executive officer Doug Ulman said he was thrilled with the final tally after COVID-19 forced the group to alter the format of the popular, annual bike ride. This year, organizers created a virtual platform called My Pelotonia, which allowed participants to be creative in what they did to raise money for cancer research.  “Anytime you do something totally new, it’s hard to predict how it will go,” Ulman said. “Everybody has been overwhelmed and impacted in various ways with what’s going on in the world, so we’re ecstatic with the results and we can’t wait to build upon them.”

Jeff Bridges Says He s Feeling Good 2 Months After His Lymphoma Diagnosis

Jeff Bridges Says He’s “Feeling Good” 2 Months After His Lymphoma Diagnosis Prevention 12/15/2020 Korin Miller © Twitter Jeff Bridges, 70, has lymphoma. While the disease is “serious,” his “prognosis is good.” Doctors explain lymphoma symptoms and how the cancer is treated. Jeff Bridges, 70, just shared a health update amid his lymphoma diagnosis. The actor says he is “feeling good” two months after announcing he has cancer. Doctors explain what to know about lymphoma, including symptoms and treatment. Jeff Bridges says he’s “feeling good” two months after revealing he has lymphoma. The actor, who announced his cancer diagnosis in October, took to Twitter to share an update about his health.

Ohio State announces passing of longtime cancer genetics researcher Albert de la Chapelle

Ohio State announces passing of longtime cancer genetics researcher Albert de la Chapelle His work helped lead to the statewide Ohio Colorectal Cancer Prevention Initiative The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has announced the passing of Dr. Albert de la Chapelle, a Distinguished University Professor in the Department of Cancer Biology and Genetics at Ohio State who played a key role in developing and leading the university’s human cancer genetics program to prominence. De la Chapelle, 87, died Thursday of natural causes, just nine months after the March 2020 passing of his wife Clara D. Bloomfield, also a Distinguished University Professor who for many years served as cancer scholar and senior adviser to the OSUCCC – James. He was in the Cancer Biology Program and formerly co-led that program when it was known as Molecular Biology and Cancer Genetics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.